Subscribe to our email newsletter, Industry Pulse, for more news on the innovations in the pharmacy ecosystem.
SUBSCRIBEPBM Policy Spotlight
Within the pharmacy landscape, there is more attention than ever on Pharmacy Benefit Manager (PBM) transparency. Federal initiatives include the ongoing FTC investigation of PBMs and implementation of the Inflation Reduction Act and American Rescue Plan Act. Additionally, numerous States are targeting PBMs for legislative reforms. A recent class-action lawsuit by an employee alleges that their employer mismanaged their employee drug benefit program. These pressures for greater PBM transparency are reshaping the pharmacy benefits landscape and have important downstream implications on employers and their brokers.
Our webinar, PBM Policy Spotlight, delves into the federal and state initiatives focused on PBM transparency. During this session, we will discuss key legislation, PBM reactions, and outline important considerations for brokers and employers to navigate and manage the impact of these changes to their pharmacy benefit plans.
Learning Objectives:
- Navigate PBM Transparency Policy Development: Explore the federal and state initiatives to regulate PBM practices and emerging litigation risks.
- Strategize for Transparency: Uncover considerations for brokers and employers, equipping them to proactively manage pharmacy benefits amidst evolving requirements and challenges.
- Today’s Solutions for Tomorrow: With increasing scrutiny on PBMs, employers can find immediate benefits of partnering with an independent pharmacy expert like Truveris to instill transparency in PBM practices today.
About the speakers:
Steve White, MBA, Vice President of Strategic Partnerships
Steve White is a seasoned professional with over 20 years of experience in the healthcare industry, specializing in pharmacy account management and sales. At Truveris, Steve serves as the Portfolio Vice President and brings with him a wealth of expertise gained from nearly 13 years of working with two of the nation’s top three PBMs in various capacities. With a deep understanding of PBM underwriting practices, Steve recognizes the vital importance of transparency in our healthcare system as we strive to advance healthcare in America.
Tish Pahl, Esq.
Tish is a highly experienced counsel to drug, cosmetic, dietary supplement, and food companies with matters before the Food and Drug Administration, the Federal Trade Commission, and other federal agencies. She is a highly regarded expert and frequent speaker on pharmaceutical supply chain security and transparency. In addition to counseling FDA-regulated entities, she has particular expertise aiding trade associations in their compliance strategies and crafting advocacy on behalf of members. Tish holds a B.S. and J.D. cum laude from Northwestern University and is a member of the District of Columbia Bar.
